Lee named inaugural Selma and Herman Seldin Distinguished Professor of Medicine
Janet S. Lee, MD, a physician-scientist in the Division of Pulmonary & Critical Care at WashU Medicine, is internationally recognized for groundbreaking research in acute lung injury.
Norris to study brain cells that help control how the body burns calories
Aaron Norris, MD, PhD, at WashU Medicine, has received a five-year $3.5 million NIH grant to study brain cells that regulate how the body burns calories and could lead to new ways to promote weight loss.
Bateman and Holtzman receive 2026 American Innovator Award
WashU Medicine researchers Randall J. Bateman, MD, and David M. Holtzman, MD, were honored for their work developing diagnostic blood tests for Alzheimer’s disease with the Bayh-Dole Coalition’s 2026 American Innovator Award.
Ready to fire
WashU biomedical engineers in Ismael Seáñez’s lab are evaluating which strategies and treatments are the most effective for spinal cord injuries.
Blood test powered by AI could transform diagnosis of dementia
A tool developed by WashU Medicine researchers can accurately distinguish among several major neurodegenerative diseases — including Alzheimer’s, Parkinson’s, frontotemporal dementia and dementia with Lewy bodies — as well as detect when these conditions overlap, potentially improving early diagnosis, monitoring and treatment.
Drewry installed as inaugural Llorin-Roa professor
Anne M. Drewry, MD, a nationally recognized leader in critical care medicine, has been installed as the inaugural Llorin-Roa Professor of Anesthesiology at WashU Medicine.
Novel tool uncovers a common genetic cause of peripheral neuropathy
A cost-effective screening tool developed by WashU Medicine researchers allows for broader genomic testing for patients with peripheral neuropathy of unknown cause.
Christopher J. Moran, MD, professor emeritus of radiology, 78
Christopher J. Moran, MD, a professor emeritus of radiology at Washington University School of Medicine in St. Louis, died April 30 of cancer. He was 78.
Gene-edited stem cell transplant shows promise for aggressive blood cancers
A new study led by WashU Medicine researchers shows that, for blood cancer patients, a genetically engineered stem cell transplant helps prevent toxic side effects and potentially improves the effectiveness of therapies.
Personalized vaccine shows promise against aggressive brain cancer
A WashU Medicine-led clinical trial has found that a personalized vaccine to treat glioblastoma appears to increase recurrence-free survival in a subset of patients after surgery.
View More Stories